Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and sweet's syndrome

Clinical and Experimental Immunology

Volumn 178, Issue 1, 2014, Pages 48-56

  Marzano, A V ^a   Fanoni, D ^a   Antiga, E ^b   Quaglino, P ^c   Caproni, M ^b   Crosti, C ^a   Meroni, P L ^a   Cugno, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Autoinflammation; Chemokines; Cytokines; Pyoderma gangrenosum; Sweet's syndrome

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CHEMOKINE; CXCL1 CHEMOKINE; CXCL16 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; CYTOKINE; FAS ANTIGEN; FAS LIGAND; GELATINASE A; GELATINASE B; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 8; L SELECTIN; RANTES; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA; ALPHA CHEMOKINE; LIGAND;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; AUTOINFLAMMATORY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUTROPHIL; PROTEIN EXPRESSION; PYODERMA GANGRENOSUM; SKIN BIOPSY; TISSUE INJURY; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD40; CHEMOKINES, CXC; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-8; LIGANDS; MALE; MIDDLE AGED; PYODERMA GANGRENOSUM; SWEET SYNDROME; T-LYMPHOCYTES;

EID: 84908217475     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12394     Document Type: Article

References (40)

1. Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 2013; 45:202-10.
2. Maverakis E, Goodarzi H, Wehrli LN, Ono Y, Garcia MS. The etiology of paraneoplastic autoimmunity. Clin Rev Allergy Immunol 2012; 42:135-44.
3. Wollina U, Haroske G. Pyoderma gangrenosum. Curr Opin Rheumatol 2011; 23:50-6.
4. Ueharaguchi Y, Kabashima K, Sasahashi M, Matsuda A, Matubara K, Matsui M. A case of pyoderma gangrenosum possibly associated with sunitinib treatment. Int J Dermatol 2013; 52:634-6.
5. Kyllo RL, Parker MK, Rosman I, Musiek AC. Ipilimumabassociated Sweet syndrome in a patient with high-risk melanoma. J Am Acad Dermatol 2014; 70:e85-86.
6. Cohen PR. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol 2009; 10:301-12.
7. Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol 2012; 13:191-211.
8. Marzano AV, Trevisan V, Lazzari R, Crosti C. Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification. J Dermatolog Treat 2011; 22:254-60.
9. Nesterovitch AB, Gyorfy Z, Hoffman MD et al. Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses. Am J Pathol 2011; 178:1434-41.
10. Aksentijevich I, Kastner DL. Genetics of monogenic autoinflammatory diseases: past successes, future challenges. Nat Rev Rheumatol 2011; 7:469-78.
11. McDermott MF, Aksentijevich I, Galon J et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999; 97:133-44.
12. Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell 2010; 140:784-90.
13. Doria A, Zen M, Bettio S et al. Autoinflammation and autoimmunity:bridging the divide. Autoimmun Rev 2012; 12:22-30.
14. Chang C. The pathogenesis of neonatal autoimmune and autoinflammatory diseases: a comprehensive review. J Autoimmun 2013; 41:100-10.
15. Zen M, Gatto M, Domeneghetti M et al. Clinical guidelines and definitions of autoinflammatory diseases: contrasts and comparisons with autoimmunity - a comprehensive review. Clin Rev Allergy Immunol 2013; 45:227-35.
16. Wise CA, Gillum JD, Seidman CE et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 2002; 11:961-9.
17. Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol 2011; 41:1203-17.
18. Marzano AV, Cugno M, Trevisan V et al. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophilmediated skin diseases. Clin Exp Immunol 2010; 162:100-7.
19. Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M. Cutaneous manifestations in patients with inflammatory bowel diseases:pathophysiology, clinical features, and therapy. Inflamm Bowel Dis 2014; 20:213-27.
20. Oka M. Pyoderma gangrenosum and interleukin 8. Br J Dermatol 2007; 157:1279-81.
21. Guenova E, Teske A, Fehrenbacher B et al. Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. Arch Dermatol 2011; 147:1203-5.
22. Kawakami T, Ohashi S, Kawa Y et al. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active Behçet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol 2004; 140:570-4.
23. Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, Beer HD. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 2007; 17:1140-5.
24. Lee P, Lee DJ, Chan C, Chen SW, Ch'en I, Jamora C. Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature 2009; 458:519-23.
25. Oppenheim JJ, Zachariae CO,Mukaida N,Matsushima K. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annu Rev Immunol 1991; 9:617-48.
26. Reguiai Z, Grange F. The role of anti-tumor necrosis factor-alpha therapy in pyoderma gangrenosum associated with inflammatory bowel disease. Am J Clin Dermatol 2007; 8:67-77.
27. Marzano AV, Tourlaki A, Alessi E, Caputo R. Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab. Clin Exp Dermatol 2008; 33:156-9.
28. Soriano A, Verecchia E, Afeltra A, Landolfi R,Manna R. IL-1β biological treatment of familial Mediterranean fever. Clin Rev Allergy Immunol 2013; 45:117-30.
29. Pene J, Chevalier S, Preisser L et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008; 180:7423-30.
30. Dardalhon V, Korn T, Kuchroo VK, Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008; 31:252-6.
31. Nalbandian A, Crispin JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 2009; 157:209-15.
32. Ruddy MJ, Wong GC, Liu XK et al. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 2004; 279:2559-67.
33. Agarwal S,Misra R, Aggarwal A. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol 2008; 35:515-19.
34. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998; 10:602-8.
35. Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996; 14:288-95.
36. Pillai S, Netravali IA, Cariappa A, Mattoo H. Siglecs and immune regulation. Annu Rev Immunol 2012; 30:357-92.
37. Wehrli P, Viard L, Bullani R, Tschopp J, French LE. Death receptors in cutaneous biology and disease. J Invest Dermatol 2000; 115:141-8.
38. Caproni M, Torchia D, Schincaglia E et al. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol 2006; 155:722-8.
39. Marzano AV, Frezzolini A, Caproni M et al. Immunohistochemical expression of apoptotic markers in drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. Int J Immunopathol Pharmacol 2007; 20:557-66.
40. Brugnolo F, Annunziato F, Sampognaro S et al. Highly Th2- skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions. J Immunol 1999; 163:1053-9.